PFKM and acute myeloid leukemia: On the other hand, the high expression of PKM, PFKM, and HK2, which code for enzymes of the glycolytic pathway (pyruvate kinase M1/2, phosphofructokinase, and hexokinase-2, respectively), correlates with poor prognosis in AML patients.